JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rimon, A.
Right arrow Articles by Shapiro, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rimon, A.
Right arrow Articles by Shapiro, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Plasmin Inhibitor of Human Plasma

IV. ITS ACTION ON PLASMIN, TRYPSIN, CHYMOTRYPSIN, AND THROMBIN

Abraham Rimon 1, Yeheskel Shamash 1, and Benyamin Shapiro 1

From the 1 From the Department of Microbiology, Tel-Aviv University, Tel-Aviv; the Marcus Memorial Blood Institute of Magen David Adom, Jaffa; and the Department of Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem, Israel

Purified agr1-proteolytic inhibitor from human plasma was shown to inhibit trypsin, chymotrypsin, plasmin, and thrombin. This inhibitor is probably identical with the inhibitor previously known as serum trypsin inhibitor, agr1-antitrypsin, or antiplasmin. The enzymes were affected by the inhibitor via two different mechanisms. Trypsin and chymotrypsin reacted instantaneously in stoichiometric manner, and the enzyme substrate had no effect on the reaction. The inhibition of plasmin and thrombin was time-dependent and of nonstoichiometric nature, and it was retarded by the presence of enzyme substrate. Even so, kinetic studies failed to show a competition reaction between the substrate and the inhibitor on a single site of the enzyme molecule. It is therefore suggested that the inhibition mechanism might be an enzymatic inactivation of the proteolytic enzymes concerned. This inactivation was irreversible in the sense that no enzymatic activity could be recovered after acid dissociation of the enzyme-inhibitor complex. It was shown by differential titration that the inhibitory activity of the inhibitor towards all four enzymes is due to a single molecular entity; this conclusion is also suggested by the high purity of the inhibitor preparation. On the basis of its stoichiometric combination with trypsin, the agr1-proteolytic inhibitor was estimated to have a molecular weight of 47,000 and to comprise about 2% of plasma proteins.

Submitted on April 18, 1966


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1966 by the American Society for Biochemistry and Molecular Biology.